mardi 22 août 2017
Johnson & Johnson ordered to pay $417M in trial over talc cancer risks
A California jury on Monday ordered Johnson & Johnson to pay $417 million US to a woman who claimed she developed ovarian cancer after using the company's talc-based products.
Articles
0 comments:
Enregistrer un commentaire